SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
0.6504
-0.0151 (-2.27%)
Jun 3, 2026, 1:17 PM EDT - Market open
SkinHealth Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 296.12 | 300.79 | 334.29 | 397.99 | 365.88 | 260.09 | |
Revenue Growth (YoY) | -8.17% | -10.02% | -16.00% | 8.78% | 40.67% | 118.39% |
Cost of Revenue | 103.9 | 104.43 | 152 | 242.88 | 117.1 | 81.55 |
Gross Profit | 192.22 | 196.36 | 182.3 | 155.11 | 248.78 | 178.54 |
Selling, General & Admin | 197.07 | 211.54 | 243.77 | 275.93 | 266.18 | 210.27 |
Research & Development | 5.73 | 5.63 | 6.3 | 10.1 | 8.44 | 8.2 |
Total Operating Expenses | 202.8 | 217.17 | 250.07 | 286.03 | 274.62 | 218.47 |
Operating Income | -10.58 | -20.8 | -67.77 | -130.92 | -25.84 | -39.93 |
Interest Income | 7.41 | 8.95 | 16.64 | 23.17 | 9.18 | 0.04 |
Interest Expense | -23.17 | -19.33 | -10.41 | -13.65 | -13.39 | -11.78 |
Other Non-Operating Income (Expense) | -22.52 | -24.26 | -25.86 | 4.33 | 81.29 | -319.86 |
Total Non-Operating Income (Expense) | -38.28 | -34.64 | -19.63 | 13.86 | 77.07 | -331.6 |
Pretax Income | -3.55 | -5.94 | -29.55 | -101.89 | 45.34 | -380.64 |
Provision for Income Taxes | 2.51 | 3.58 | -0.45 | -1.77 | 1.12 | -1.88 |
Net Income | -6.05 | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Net Income to Common | -6.05 | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Shares Outstanding (Basic) | 127 | 126 | 124 | 132 | 148 | 102 |
Shares Outstanding (Diluted) | 132 | 136 | 142 | 132 | 149 | 102 |
Shares Change (YoY) | 2.05% | -4.70% | 8.21% | -11.33% | 45.43% | 197.77% |
EPS (Basic) | -0.04 | -0.08 | -0.23 | -0.76 | 0.30 | -3.71 |
EPS (Diluted) | -0.17 | -0.16 | -0.36 | -0.76 | -0.23 | -3.71 |
Shares Outstanding | 129.15 | 127.52 | 124.92 | 122.9 | 132.22 | 150.6 |
Free Cash Flow | 28.45 | 37.18 | 15.38 | 17.93 | -117.45 | -39.56 |
Free Cash Flow Growth | -23.48% | 141.79% | -14.21% | - | - | - |
Free Cash Flow Per Share | 0.22 | 0.27 | 0.11 | 0.14 | -0.79 | -0.39 |
Gross Margin | 64.91% | 65.28% | 54.53% | 38.97% | 68.00% | 68.65% |
Operating Margin | -3.57% | -6.92% | -20.27% | -32.89% | -7.06% | -15.35% |
Profit Margin | -2.04% | -3.16% | -8.70% | -25.16% | 12.09% | -145.63% |
FCF Margin | 9.61% | 12.36% | 4.60% | 4.50% | -32.10% | -15.21% |
EBITDA | 13.94 | 4.55 | -34.09 | -96.24 | -2.97 | -22 |
EBITDA Margin | 4.71% | 1.51% | -10.20% | -24.18% | -0.81% | -8.46% |
EBIT | -10.58 | -20.8 | -67.77 | -130.92 | -25.84 | -39.93 |
EBIT Margin | -3.57% | -6.92% | -20.27% | -32.89% | -7.06% | -15.35% |
Effective Tax Rate | -70.60% | -60.31% | 1.53% | 1.74% | 2.46% | 0.49% |